Volume 33, Issue 1 pp. 107-112
Article
Full Access

Estrogen metabolism in the (New Zealand black × New Zealand white)F1 Murine model of systemic lupus erythematosus

Alan N. Baer MD

Corresponding Author

Alan N. Baer MD

Division of Rheumatology, Department of Medicine, State University of New York at Buffalo, and the Veterans Administration Medical Center, Buffalo, New York.

Division of Rheumatology, Stat University of New York at Buffalo, 3495 Bailey Avenue, Buffalo, NY 14215Search for more papers by this author
Floyd A. Green MD

Floyd A. Green MD

Division of Rheumatology, Department of Medicine, State University of New York at Buffalo, and the Veterans Administration Medical Center, Buffalo, New York.

Search for more papers by this author
First published: January 1990
Citations: 7

Abstract

Hepatic microsomal estrogen metabolism was analyzed in the (New Zealand black × New Zealand white)F1 ([NZB × NZW]F1) murine model of systemic lupus erythematosus. Both the estrogen 2-hydroxylase activity (per mg microsomal protein) and the hepatic cytochrome P-450 content were higher in premorbid (NZB × NZW)F1 mice, as compared with similarly aged nonautoimmune mice. However, these differences were not associated with alterations in the relative formation of the 2-hydroxylated and the 16α-hydroxylated metabolites. The development of overt nephritis was associated with a decrease in estrogen metabolic activity, but not with any alteration in the distribution of estrogen metabolites. Thus, estrogen metabolism was not altered in premorbid (NZB × NZW)F1 mice in a manner that would result in abnormal retention of hormonally active metabolites.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me